After a successful Exec Corporate career and I am now running my own Company with a simple mission - to help others grow (individuals, teams, or organisations) by seeing their potential and reaching their goals. I am actively leveraging my past Corporate and Coaching experience and expertise as follows;-Executive Coaching & Mentorship (ranging from emerging talent to MDs)-Team facilitation (bespoke one off or a series of events to support team performance towards a common goal and… Show more After a successful Exec Corporate career and I am now running my own Company with a simple mission - to help others grow (individuals, teams, or organisations) by seeing their potential and reaching their goals. I am actively leveraging my past Corporate and Coaching experience and expertise as follows;-Executive Coaching & Mentorship (ranging from emerging talent to MDs)-Team facilitation (bespoke one off or a series of events to support team performance towards a common goal and purpose)-NED / Strategic advisor for smaller companies or consultancies (e.g. Visions4Health)-Consultancy value creation work in several multinational Pharma/Biotech companies-Trustee for North Devon Hospice (pro bono) Show less

Strategic partner in the largest franchise within Novartis ($6+ billion), delivering a broad range of access, health economics and policy requirements for assets from early pipeline through to launch, and from launch through Life Cycle Management to the end of exclusivity. Addressed top 10 international market needs (including trade offs) and BD&L assessments from an access point of view. Secured top team cultural survey results.

Exec Board level role for $0.6+ billion business at the time. Functionally responsible for external affairs, Health Technology Appraisals (HTAs), national/specialised & local commissioning, channel management and new product (pipeline) planning. Included Policy & Public Affairs and was an active member of the professional trade societies (e.g. ABPI). Team of 55 (HQ and field based).

National HTAs in England, Wales, Scotland, N Ireland.

Medical Affairs, Clinical Development (global and local studies PhII-IV), publication strategy & planning (congresses and peer reviewed publications), field based MSL team, Biostats. Team of n=45 (HQ and field based).

Medics, scientific advisors, MSLs, clinical project managers, across multiple Therapeutic Areas.

Exec Board level role. Started up pan European delivery of PhIIIb and PhIV (interventional and observational) studies.

Pan Europe medical affairs role in osteoporosis then CV then GI.

Manager of medical information, safety, medical affairs, KOLs, scientific publications/congress activities.